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趋势和在研产品线等，随后分析了 G 公司所处的宏观环境（PEST 分析）、行业环境、G
公司自身的竞争力状况（波特五力模型分析）和 G 公司内部资源和能力等，同时重点分
析了新医改方案的整体思路、主要内容及其对医药行业、制药企业和 G 公司的影响。在

























Pharmaceuticals is one of the most dynamic industry and the pharmaceutical market is a 
specialized and policy-oriented market. Healthcare reform is a hot topic all over the world. 
Chinese government announced the new plan about healthcare reform on 7th Apr, 2009. There 
is no doubt that the new reform plan will have great   influence to the competitive dynamics 
of pharmaceutical market. How to clarify the market trend and grasp the opportunity for 
growth is a big challenge for pharmaceutical enterprise. 
This article focuses on the competitive strategy of G Company under the conditions of 
healthcare reform. First part is the general introduction about G Company and its business. 
The second part is the analysis about the internal and external environment and factors that 
will influence the development of G Company. We specially analyze the content of the 
healthcare reform and the impact to G company. The third part is the strategy options got from 
SWOT & BCG matrix analysis. Final part is about the implementation and adjustment of 
competitive strategy.  
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写机会，我试图结合三年 MBA 课程的收获和长期医药领域工作经验，认真审视 G
公司各业务领域，为制药企业在新医改条件下的健康发展提供一些建议。 
第二节 研究方法 















                                                        
1 (美)彼得·德鲁克者：《管理的实践》（原书第 6版），机械工业出版社，2006 年 5 月，P43。 































































































































































架构图如图 1 所示。 
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 中国第一家通过 ISO14001 认证的制药企事业 
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